In addition, it would be interesting to investigate the S. aureus-specific CD4+ Tsrm response in patients with atopic dermatitis, a chronic and relapsing inflammatory skin disorder associated with skin barrier impairment and the predominant S. aureus colonization (66). The gene discussed is CD4; the disease is atopic eczema.